QUALITY OF LIFE IN DIFFERENT STAGES OF COLORECTAL PATIENTS ATTENDED AT THE SOCIAL SECURITY MEXICAN INSTITUTE
Author(s)
Contreras-Hernandez I1, Balderas-Peña LMA2, Mould-Quevedo J3, Sat-Muñoz D4, Garduño-Espinosa J1, Morgan-Villela G41Social Security Mexican Institute, Mexico City, Mexico, 2Social Security Mexican Institute, pecialties' Hospital, Western National Medical Center, Guadalajara, Mexico, 3Pfizer Mexico, Mexico City, Mexico, 4Social Security Mexican Institute, Guadalajara, Mexico
OBJECTIVES The aim of this study was to evaluate the quality of life (QOL) of colorectal cancer patients seeking care at a tertiary referral center within the Social Security Mexican Institute (IMSS). METHODS Quality of life questionnaires were administered to colorectal cancer patients seeking care at the Hospital de Especialidades del Centro Medico Nacional de Occidente (CMNO) from July 2008 to February 2009. Evaluated patients under went informed consent, were 16 years of age or older, and had a colorectal cancer histological diagnosis (stage I,II, III and IV)). Patients were excluded if they had a second malignant neoplasm or incomplete information. To evaluate QOL, the validated Spanish version of the EORTC QLQ-C30 was administered to patients. This questionnaire evaluates global health status, five functional domains (physical, role, emotional, cognitive and social), three symptom scales (fatigue, nausea and vomiting, pain), and six single items (dyspnea, insomnia, appetite loss, constipation, diarrhea, financial difficulties) on a scale from 0 to 100 (0=death, 100=perfect health). The assessment calculates means and ranges for EORTC QLQ-C30 score items and statistical differences were estimated through ANOVA tests. RESULTS A total of 29 colorectal cancer patients were included in the analysis. The mean age of evaluated patients was 54 years±SD13, 55% were female, 72% were married, and 15% had completed elementary school. Patients presented various clinical stages of colorectal cancer, specifically I-1 (3%), II-9 (31%), III-9 (31%) IV-10 (34%). Global Health Status showed the following results: I:83.33, II:67.59, III:74.07, IV:67.50; p=0.87. On the other hand, patients with later stages of CRC reported greater fatigue (I-100, II-67, III-80, IV-47;p=0.08) and pain (I-83, II-50, III-67, IV-48; p=0.005). CONCLUSIONS Significant differences were observed in Mexican colorectal cancer patients symptoms in their clinical stages.
Conference/Value in Health Info
2009-09, ISPOR Latin America 2009, Rio de Janeiro, Brazil
Value in Health, Vol. 12, No. 7 (October 2009)
Code
PCN34
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Oncology